Evidence map›Paper›PMID 28274688›Full record

ArticleThe international journal of biochemistry & cell biology2017

Interleukin 2 and interleukin 10 function synergistically to promote CD8

Xiaogang Li, Ping Lu, Bo Li, Wanfu Zhang, Rong Yang, Yan Chu, Kaiyuan Luo

Open access · greenAbstract read
In one paragraph

Article in The international journal of biochemistry & cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Interleukine-2 serum level in breast cancer patients.Caspian journal of internal medicine · 2023
    Article
  10. Article
  11. Article
  12. Active Ingredients fromCurrent issues in molecular biology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xiaogang LiDepartment of General Surgery, The Second People's Hospital of Yunnan Province, Kunming, Yunnan 650021, China.
Ping LuScience and Education Division, The Second People's Hospital of Yunnan Province, 176 Qingnian Road, Kunming, Yunnan 650021, China. Electronic address: pinglukm003@qq.com.
Bo LiDepartment of General Surgery, The Second People's Hospital of Yunnan Province, Kunming, Yunnan 650021, China.
Wanfu ZhangDepartment of General Surgery, The Second People's Hospital of Yunnan Province, Kunming, Yunnan 650021, China.
Rong YangDepartment of General Surgery, The Second People's Hospital of Yunnan Province, Kunming, Yunnan 650021, China.
Yan ChuDepartment of General Surgery, The Second People's Hospital of Yunnan Province, Kunming, Yunnan 650021, China.
Kaiyuan LuoDepartment of General Surgery, The Second People's Hospital of Yunnan Province, Kunming, Yunnan 650021, China.
Second People's Hospital of Yunnan Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The precise role of interleukin (IL)-10 in breast cancer is not clear. Previous studies suggested a tumor-promoting role of IL-10 in breast cancer, whereas recent discoveries that IL-10 activated and expanded tumor-resident CD8

Indexed as

Breast NeoplasmsCD4 AntigensCD4-Positive T-LymphocytesCell ProliferationCell SurvivalDrug SynergismFemaleHumansInterleukin-10Interleukin-2Interleukin-2 Receptor alpha SubunitMiddle AgedT-Lymphocytes, RegulatoryCD4 AntigensIL10 protein, humanInterleukin-10Interleukin-2Interleukin-2 Receptor alpha SubunitBreast cancerCD8+ T cellInterleukin 10Interleukin 2

Identifiers

PMID28274688
PMCPMC7185534
OpenAlexW2594259396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.